default author photo

Li Chen

Southeast University - School of Public Health

Nanjing, Jiangsu

China

SCHOLARLY PAPERS

2

DOWNLOADS

161

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Immunogenicity and Safety of a Recombinant gE-Fc Fusion Protein Subunit Vaccine for Herpes Zoster in Adults ≥50 Years of Age: A Randomised, Active-Controlled, Non-Inferiority Trial

Number of pages: 30 Posted: 09 Apr 2025
Chinese Center for Disease Control and Prevention (China CDC) - Jiangsu Provincial Center for Disease Control and Prevention, Government of the People's Republic of China - National Institutes for Food and Drug Control, Wuxi Centre for Disease Control and Prevention, Beijing Luzhu Biotechnology Co., Ltd., Chinese Center for Disease Control and Prevention (China CDC) - Jiangsu Provincial Center for Disease Control and Prevention, Nanjing Medical University, Wuxi Centre for Disease Control and Prevention, Beijing Luzhu Biotechnology Co., Ltd., Chinese Center for Disease Control and Prevention (China CDC) - Jiangsu Provincial Center for Disease Control and Prevention, Southeast University - School of Public Health, Government of the People's Republic of China - National Institutes for Food and Drug Control, Wuxi Centre for Disease Control and Prevention, Wuxi Centre for Disease Control and Prevention, Government of the People's Republic of China - National Institutes for Food and Drug Control, Government of the People's Republic of China - National Institutes for Food and Drug Control, Southeast University - School of Public Health, Southeast University - School of Public Health, Yunnan University, Yunnan University, Chinese Center for Disease Control and Prevention (China CDC) - Jiangsu Provincial Center for Disease Control and Prevention, Beijing Luzhu Biotechnology Co., Ltd., China Pharmaceutical University - State Key Laboratory of Natural Medicines, National Institutes for Food and Drug Control and Nanjing Medical University
Downloads 139 (527,599)

Abstract:

Loading...

Herpes zoster, gE-Fc fusion vaccine, subunit vaccine, immunogenicity, safety, non-inferiority trial

2.

Safety and Immunogenicity of Ad5-Ncov Administered Intradermally By Needle-Free Injector In Rats

Number of pages: 31 Posted: 25 Jul 2024
Southeast University - School of Public Health, affiliation not provided to SSRN, Southeast University, Academy of Military Medical Sciences - Institute of Biotechnology, Nanjing Medical University and Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology
Downloads 22 (1,424,331)

Abstract:

Loading...

COVID-19, adenovirus type-5 vector-based COVID-19 vaccine, immunogenicity, safety, needle-free injector